# Correction: Afjei et al. A New Nrf2 Inhibitor Enhances Chemotherapeutic Effects in Glioblastoma Cells Carrying p53 Mutations. Cancers 2022, 14, 6120

**Authors:** Rayhaneh Afjei, Negar Sadeghipour, Sukumar Uday Kumar, Mallesh Pandrala, Vineet Kumar, Sanjay V. Malhotra, Tarik F. Massoud, Ramasamy Paulmurugan

PMC · DOI: 10.3390/cancers17142408 · 2025-07-21

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}
- **Diseases:** Glioblastoma (MESH:D005909)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12293578/full.md

---
Source: https://tomesphere.com/paper/PMC12293578